James Hsiao

Local Partner, Hong Kong SAR



James Hsiao is a local partner in our White Collar practice, based in Hong Kong. He has over 10 years of experience in international anti-corruption investigations, regulatory and compliance matters, complex cross-border and commercial litigation, international arbitration, anti-money laundering, and risk management across Asia and globally.

James regularly represents companies, investors and individuals in connection with internal investigations and enforcement actions, including anti-bribery and anti-corruption actions such as FCPA related investigations, fraud, embezzlement, trade/sanctions, compliance audits and risk assessments, development of compliance policies and programs, and pre-transaction / pre-investment due diligence. He also conducts comprehensive compliance trainings for clients. His practice includes advising multinational and Asia-based companies in the finance, life science, biotech, pharmaceutical and technology sectors on a range of matters.

Before joining the White Collar team, James worked at international law firms in Hong Kong, New York and Los Angeles. He is a former prosecutor and has spent time on a client secondment at an American multinational investment bank and financial services company. James also has more than 7 years of experience working in various engineering roles at a number of technology start-ups and companies prior to law school.

Bars and Courts
Solicitor of the High Court of Hong Kong
New York State Bar
California State Bar
Juris Doctor
Boston University School of Law
Master of Arts
City University of New York
Bachelor of Arts
City University of New York


James' experience* includes representing: 

  • a U.S.-listed life sciences company to conduct multiple internal investigations into allegations of distributor fraud, bribery, employee embezzlement, and sample misuse across a variety of jurisdictions, including Australia, China, Japan, Malaysia, and South Africa. 
  • a U.S.-listed industrial conglomerate to conduct internal investigation into allegations of revenue recognition fraud and falsification of documentation in a China-based subsidiary.
  • a British life sciences company in landmark anti-bribery investigation in multiple jurisdictions (China, U.S., U.K.); conducted extensive internal investigations into China operations in connection with the same.
  • a number of individuals in a joint U.S. DOJ/OFAC/BIS investigation into alleged violations of U.S. trade sanctions by a Chinese telecom company.
  • a U.S.-listed China-based e-commerce company to conduct a financial fraud internal investigation regarding allegations of accounting and securities fraud by a short-seller.
  • a multinational U.S.-listed medical device company in connection with its DOJ-appointed compliance monitorship; represented the company in presentations with the DOJ-appointed monitor.
  • a multinational U.S.-listed company in an international arbitration at the HKIAC involving a dispute with a Chinese battery supplier.
  • an individual defendant before the SEC regarding allegations of insider trading.
  • a major British investment bank in state and federal securities lawsuits relating to residential mortgage-backed securities. 

* Includes experience prior to joining White & Case


The War on Cybercrime: How Far Can You Go?, Corporate Counsel (April 2013), Co-author

Awards and Recognition

Named in ALB Asia Super 50 Disputes Lawyers in Hong Kong, 2021